Clinical Research Directory
Browse clinical research sites, groups, and studies.
Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B
Sponsor: PT. Prodia Stem Cell Indonesia
Summary
The study aims to evaluate the effect of allogeneic mesenchymal stem cell therapy on patients who suffered from liver cirrhosis caused by Hepatitis B.
Official title: Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B: Phase I/ II Study
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
12
Start Date
2018-05-17
Completion Date
2028-12-20
Last Updated
2026-02-25
Healthy Volunteers
No
Conditions
Interventions
Allogeneic Umbilical Cord Mesenchymal Stem Cell
All research samples will be treated by Intravenous injection of allogeneic mesenchymal stem cells and hemodynamic observation will be done for 24 hours after treated. Periodic post-treatment observation will be done on 1st month, 3rd month, and 6th month after therapy. The Independent variable in this research is Child-Pugh B Cirrhosis caused by Hepatitis B, while the dependent variable is the degree of liver function damage consisting of an examination of liver function, Child-Pugh score, and MELD score.
Locations (1)
Cipto Mangunkusumo hospital
Jakarta, DKI Jakarta, Indonesia